[Coexistence of virus C and antinuclear antibodies in chronic active hepatitis: diagnostic and therapeutic implications].
Pirotte
J
J
Université de Liège, Service d'Hépatogastroentérologie.
D000974:Antibodies, Antinuclear / Q000302:isolation & purification*; D004359:Drug Therapy, Combination; D005260:Female; D018937:Hepatitis C Antibodies / Q000302:isolation & purification*; D006521:Hepatitis, Chronic / Q000276:immunology* / Q000821:virology; D006801:Humans; D007158:Immunologic Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007370:Interferon Type I / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000276:immunology; D011994:Recombinant Proteins
D000974:Antibodies, Antinuclear; D018937:Hepatitis C Antibodies; D007166:Immunosuppressive Agents; D007370:Interferon Type I; D011994:Recombinant Proteins
Coexistence du virus C et d'anticorps antinucleaires dans l'hepatite chronique active: implications diagnostiques et therapeutiques.